XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

Israel, 25 pages report, published by GlobalData

Report ThumbnailAugust-2017
Summary

XTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus (SLE); and rHuEPO is a compound developed to prolongate multiple myeloma advanced-stage patients' survival. The company offers identifying, validating

Read More
  • List of Figures
  • XTL Biopharmaceuticals Ltd, Performance Chart
  • XTL Biopharmaceuticals Ltd, Ratio Charts
Read More
  • List of Tables
  • XTL Biopharmaceuticals Ltd, Key Information
  • XTL Biopharmaceuticals Ltd, Key Ratios
  • XTL Biopharmaceuticals Ltd, Share Data
  • XTL Biopharmaceuticals Ltd, Major Products and Services
  • XTL Biopharmaceuticals Ltd, History
  • XTL Biopharmaceuticals Ltd, Key Employees
  • XTL Biopharmaceuticals Ltd, Key Employee Biographies
  • XTL Biopharmaceuticals Ltd, Key Operational Heads
  • XTL Biopharmaceuticals Ltd, Other Locations
  • XTL Biopharmaceuticals Ltd, Subsidiaries
  • XTL Bio
Read More
  • Table of Contents
  • Section 1 - About the Company
  • XTL Biopharmaceuticals Ltd - Key Information
  • XTL Biopharmaceuticals Ltd - Overview
  • XTL Biopharmaceuticals Ltd - Key Employees
  • XTL Biopharmaceuticals Ltd - Key Employee Biographies
  • XTL Biopharmaceuticals Ltd - Key Operational Heads
  • XTL Biopharmaceuticals Ltd - Major Products and Services
  • XTL Biopharmaceuticals Ltd - History
  • XTL Biopharmaceuticals Ltd - Company Statement
  • XTL Biopharmaceuticals Ltd - Locations And Sub
Read More

Please select a license type

Share

Related Products

GlobalDataXTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailXTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 679714
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved